Literature DB >> 4091529

Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives.

I O Kibwage, J Hoogmartens, E Roets, H Vanderhaeghe, L Verbist, M Dubost, C Pascal, P Petitjean, G Levol.   

Abstract

The MICs of erythromycins A, B, C, and D and some of their derivatives were determined against 21 gram-positive and 15 gram-negative microorganisms. Antibacterial activity was confined to gram-positive and very few gram-negative bacteria. Erythromycin B was somewhat less active than erythromycin A, and erythromycin C and D showed about half that activity or even less. Most other derivatives had negligible activity. Determination of potency by diffusion and turbidimetric assays were in line with MICs. The examination of the results of these assays, however, revealed that there are differences between the data of different laboratories, depending on the microorganisms and conditions used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4091529      PMCID: PMC176346          DOI: 10.1128/AAC.28.5.630

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Determination of erythromycin and its derivatives by gas-liquid chromatography.

Authors:  K Tsuji; J H Robertson
Journal:  Anal Chem       Date:  1971-06       Impact factor: 6.986

2.  Acid degradation of erythromycin A and erythromycin B.

Authors:  P Kurath; P H Jones; R S Egan; T J Perun
Journal:  Experientia       Date:  1971-04-15

3.  Antibiotic glycosides. 8. Erythromycin D, a new macrolide antibiotic.

Authors:  J Majer; J R Martin; R S Egan; J W Corcoran
Journal:  J Am Chem Soc       Date:  1977-03-02       Impact factor: 15.419

Review 4.  Erythromycin.

Authors:  M J Gribble; A W Chow
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

5.  High-performance liquid chromatographic determination of erythromycin.

Authors:  K Tsuji; J F Goetz
Journal:  J Chromatogr       Date:  1978-01-11
  5 in total
  11 in total

1.  Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.

Authors:  George Tegos; Frank R Stermitz; Olga Lomovskaya; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

3.  The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.

Authors:  Gopinath Kasetty; Ravi K V Bhongir; Praveen Papareddy; Heiko Herwald; Arne Egesten
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  The Berkeleylactones, Antibiotic Macrolides from Fungal Coculture.

Authors:  Andrea A Stierle; Donald B Stierle; Daniel Decato; Nigel D Priestley; Jeremy B Alverson; John Hoody; Kelly McGrath; Dorota Klepacki
Journal:  J Nat Prod       Date:  2017-03-22       Impact factor: 4.050

5.  Tissue distribution and excretion of radioactively labelled compounds in the Wistar rat after administration of [N-methyl-14C]-erythromycin A.

Authors:  I O Kibwage; M Michiels; R Hendriks; T Cachet; A Verbruggen; J Hoogmartens; H Vanderhaeghe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

6.  Toward a global picture of bacterial secondary metabolism.

Authors:  Mohammad R Seyedsayamdost
Journal:  J Ind Microbiol Biotechnol       Date:  2019-01-25       Impact factor: 3.346

7.  Heterologous erythromycin production across strain and plasmid construction.

Authors:  Lei Fang; Marc Guell; George M Church; Blaine A Pfeifer
Journal:  Biotechnol Prog       Date:  2017-10-13

8.  Metabolically engineered Escherichia coli for efficient production of glycosylated natural products.

Authors:  Salvador Peirú; Eduardo Rodríguez; Hugo G Menzella; John R Carney; Hugo Gramajo
Journal:  Microb Biotechnol       Date:  2008-08-04       Impact factor: 5.813

9.  Effects of Acute and Chronic Exposure to Residual Level Erythromycin on Human Intestinal Epithelium Cell Permeability and Cytotoxicity.

Authors:  Haihong Hao; Kuppan Gokulan; Silvia A Piñeiro; Katherine M Williams; Zonghui Yuan; Carl E Cerniglia; Sangeeta Khare
Journal:  Microorganisms       Date:  2019-09-06

10.  Consistency evaluation between matrix components ratio and microbiological potency of tylosin major components.

Authors:  Khadijeh Hamidian; Mohsen Amini; Nasrin Samadi
Journal:  Daru       Date:  2018-10-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.